Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 109.92 M106.58 M131.28 M127.08 M 474.86 M Research & development ———— — Operating income 89.8 M151.34 M160.73 M125.15 M 527.02 M Non-Operating Income, Total 8.25 M8.71 M8.92 M9.37 M 35.25 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 8.25 M8.71 M8.92 M9.37 M 35.25 M Unusual income/expense ———— — Pretax income 98.05 M160.05 M169.65 M134.51 M 562.26 M Equity in earnings ———— — Taxes 517 K48.27 M53.1 M36.2 M 138.09 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 97.53 M111.78 M116.55 M99.83 M 425.7 M Discontinued operations ———— — Net income 97.53 M111.78 M116.55 M99.83 M 425.7 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 97.53 M111.78 M116.55 M99.83 M 425.7 M Basic earnings per share (Basic EPS) 1.471.671.751.51 6.4 Diluted earnings per share (Diluted EPS) 1.421.631.71.47 6.22 Average basic shares outstanding 66.24 M66.96 M66.63 M66.55 M — Diluted shares outstanding 68.89 M68.59 M68.43 M68.43 M — EBITDA 105.79 M161.64 M169.03 M133.19 M 569.65 M EBIT 89.8 M151.34 M160.73 M125.15 M 527.02 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 15.99 M10.3 M8.3 M8.04 M 42.63 M